NASDAQ: SOBRSobr Safe Inc Stock
$0.28-0.01 (-3.45%)
Updated Apr 26, 2024
SOBR Price
$0.28
Fair Value Price
$0.15
Market Cap
$5.66M
52 Week Low
$0.20
52 Week High
$2.33
P/E
-0.51x
P/B
2.78x
P/S
52.01x
PEG
N/A
Dividend Yield
N/A
Revenue
$157.29k
Earnings
-$10.21M
Gross Margin
39.6%
Operating Margin
-5,982.79%
Profit Margin
-6,494.1%
Debt to Equity
2.05
Operating Cash Flow
-$6M
Beta
0.71
Next Earnings
Jun 7, 2024
Ex-Dividend
N/A
Next Dividend
N/A
SOBR Overview
SOBR Safe, Inc. develops a non-invasive alcohol detection and identity verification systems. It engages in the development of SOBRcheck, a stationary identification and alcohol monitoring product; SOBRsure, a transdermal, alcohol-detecting wearable band; and SOBRSafe software platform for non-invasive alcohol detection and identity verification. The company was formerly known as TransBiotec, Inc. and changed its name to SOBR Safe, Inc. in March 2020. The company was founded in 2004 and is based in Greenwood Village, Colorado.
Zen Score
–
Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SOBR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SOBR ($0.28) is overvalued by 93.53% relative to our estimate of its Fair Value price of $0.15 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
SOBR ($0.28) is not significantly undervalued (93.53%) relative to our estimate of its Fair Value price of $0.15 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
SOBR is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more SOBR due diligence checks available for Premium users.
Be the first to know about important SOBR news, forecast changes, insider trades & much more!
SOBR News
Valuation
SOBR fair value
Fair Value of SOBR stock based on Discounted Cash Flow (DCF)
Price
$0.28
Fair Value
$0.15
Overvalued by
91.48%
SOBR ($0.28) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
SOBR ($0.28) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
SOBR is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
SOBR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.51x
Industry
-7.72x
Market
41.14x
SOBR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.78x
Industry
3.09x
SOBR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SOBR's financial health
Profit margin
Revenue
$35.5k
Net Income
-$2.5M
Profit Margin
-7,149.8%
SOBR's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
SOBR's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$6.1M
Liabilities
$4.2M
Debt to equity
2.05
SOBR's short-term assets ($3.37M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SOBR's short-term assets ($3.37M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SOBR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$1.2M
Investing
$0.0
Financing
-$111.4k
SOBR's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
SOBR vs Scientific & Technical Instrument Stocks
Sobr Safe Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.